Log in

CMA Welcomes Skin-Cancer Study Results

23 Oct 2015 11:22 AM | Anonymous

At the Blackmores Institute Symposium today, Chief Executive Officer of Complementary Medicines Australia (CMA), Mr Carl Gibson, welcomed results from a University of Sydney study1, published in the New England Journal of Medicine, which show that vitamin B3 (nicotinamide) can cut the risk of new skin cancers by 23 per cent.


Read the release here

Call us on 02 6260 4022 or fax 02 6260 4122
Follow us online
 

Address: PO Box 450 Mawson, ACT 2607 Australia

Powered by Wild Apricot Membership Software